Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Han Liang

Showing results (631-640 of 660) with videos related to

Pageof 66
Sort By:
Nature Communications|May 30, 2014
A pan-cancer proteomic perspective on The Cancer Genome AtlasRehan Akbani, Patrick Kwok Shing Ng, Henrica M J Werner, et al.
Nature Communications|November 29, 2017
Transcribed ultraconserved region 339 promotes carcinogenesis by modulating tumor suppressor microRNAsIvan Vannini, Petra M Wise, Kishore B Challagundla, et al.
Cancer Discovery|April 9, 2024
ZNF397 Deficiency Triggers TET2-Driven Lineage Plasticity and AR-Targeted Therapy Resistance in Prostate CancerYaru Xu, Yuqiu Yang, Zhaoning Wang, et al.
Nature Communications|January 10, 2018
Publisher Correction: Transcribed ultraconserved region 339 promotes carcinogenesis by modulating tumor suppressor microRNAsIvan Vannini, Petra M Wise, Kishore B Challagundla, et al.
Innovation (Cambridge (Mass.))|July 9, 2026
Chinese consensus on first-line precision therapy for advanced gastric cancerXiaotian Zhang, Weiqi Sheng, Tong Xie, et al.
Cell Reports|April 19, 2018
ZRANB1 Is an EZH2 Deubiquitinase and a Potential Therapeutic Target in Breast CancerPeijing Zhang, Zhenna Xiao, Shouyu Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 2, 2016
Clinical and Biologic Significance of MYC Genetic Mutations in De Novo Diffuse Large B-cell LymphomaZijun Y Xu-Monette, Qipan Deng, Ganiraju C Manyam, et al.
Cell|January 12, 2019
Bacteria-to-Human Protein Networks Reveal Origins of Endogenous DNA DamageJun Xia, Li-Ya Chiu, Ralf B Nehring, et al.
Cell|July 6, 2024
Neoadjuvant PARPi or chemotherapy in ovarian cancer informs targeting effector Treg cells for homologous-recombination-deficient tumorsYikai Luo, Yu Xia, Dan Liu, et al.
Hepatobiliary & Pancreatic Diseases International : HBPD INT|November 14, 2022
Chinese expert consensus on organ protection of transplantation (2022 edition)Jian-Hui Li, Xiao Xu, Yan-Feng Wang, et al.
Pageof 66

Showing results (631-640 of 660) with videos related to

Sort By:
Pageof 66
Nature Communications|May 30, 2014
A pan-cancer proteomic perspective on The Cancer Genome AtlasRehan Akbani, Patrick Kwok Shing Ng, Henrica M J Werner, et al.
Nature Communications|November 29, 2017
Transcribed ultraconserved region 339 promotes carcinogenesis by modulating tumor suppressor microRNAsIvan Vannini, Petra M Wise, Kishore B Challagundla, et al.
Cancer Discovery|April 9, 2024
ZNF397 Deficiency Triggers TET2-Driven Lineage Plasticity and AR-Targeted Therapy Resistance in Prostate CancerYaru Xu, Yuqiu Yang, Zhaoning Wang, et al.
Nature Communications|January 10, 2018
Publisher Correction: Transcribed ultraconserved region 339 promotes carcinogenesis by modulating tumor suppressor microRNAsIvan Vannini, Petra M Wise, Kishore B Challagundla, et al.
Innovation (Cambridge (Mass.))|July 9, 2026
Chinese consensus on first-line precision therapy for advanced gastric cancerXiaotian Zhang, Weiqi Sheng, Tong Xie, et al.
Cell Reports|April 19, 2018
ZRANB1 Is an EZH2 Deubiquitinase and a Potential Therapeutic Target in Breast CancerPeijing Zhang, Zhenna Xiao, Shouyu Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 2, 2016
Clinical and Biologic Significance of MYC Genetic Mutations in De Novo Diffuse Large B-cell LymphomaZijun Y Xu-Monette, Qipan Deng, Ganiraju C Manyam, et al.
Cell|January 12, 2019
Bacteria-to-Human Protein Networks Reveal Origins of Endogenous DNA DamageJun Xia, Li-Ya Chiu, Ralf B Nehring, et al.
Cell|July 6, 2024
Neoadjuvant PARPi or chemotherapy in ovarian cancer informs targeting effector Treg cells for homologous-recombination-deficient tumorsYikai Luo, Yu Xia, Dan Liu, et al.
Hepatobiliary & Pancreatic Diseases International : HBPD INT|November 14, 2022
Chinese expert consensus on organ protection of transplantation (2022 edition)Jian-Hui Li, Xiao Xu, Yan-Feng Wang, et al.
Pageof 66